BFSG LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

BFSG LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Sell	4,567 -1,971	-30%	-$65.6K	0.01%	325
2026 Q1	$197K	Sell	6,538 -1,732	-21%	-$55.7K	0.02%	277
2025 Q4	$258K	Sell	8,270 -520	-6%	-$12.8K	0.03%	240
2025 Q3	$178K	Sell	8,790 -2,170	-20%	-$38.1K	0.02%	286
2025 Q2	$184K	Hold	10,960	–	–	0.02%	261
2025 Q1	$168K	Buy	10,960 +790	+8%	+$14.1K	0.02%	255
2024 Q4	$224K	Sell	10,170 -745	-7%	-$13.6K	0.03%	225
2024 Q3	$197K	Sell	10,915 -2,490	-19%	-$43.6K	0.02%	252
2024 Q2	$218K	Sell	13,405 -1,275	-9%	-$19.6K	0.03%	226
2024 Q1	$207K	Hold	14,680	–	–	0.03%	234
2023 Q4	$153K	Sell	14,680 -860	-6%	-$8.03K	0.02%	269
2023 Q3	$159K	Buy	+15,540	New	+$145K	0.03%	234

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

BFSG LLC's TEVA Position: Q2 2026 in Review

BFSG LLC reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 30% in Q2 2026, selling an estimated $65.6K and leaving 4,567 shares worth $155K. The position accounts for 0.01% of the portfolio, ranked #325.

BFSG LLC first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $258K in Q4 2025. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

BFSG LLC held 4,567 shares of Teva Pharmaceutical Industries Limited worth $155K as of Q2 2026.
BFSG LLC sold 1,971 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $65.6K.
Teva Pharmaceutical Industries Limited made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #325 holding.
BFSG LLC first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and has held it in 12 quarters since.
BFSG LLC's Teva Pharmaceutical Industries Limited position peaked at $258K in Q4 2025.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.